Open-Label Study to Evaluate Safety of A Single Dose of SYM-1219

Clinical trial NCT02452866 · COMPLETED

Trial details

NCT number: NCT02452866
Sponsor: Symbiomix Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bacterial Vaginosis

Start date: 2015-06-01
Primary completion: 2015-10-01
Enrollment: 325

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.